As we reflect on 2023 and make predictions for 2024, it is remarkable the number of significant events occurring this past year that will be impactful for the activities of the life sciences industry going forward. Although there was no single moment like the passage of the Affordable Care Act in 2010, there are numerous distinct events that will loom large in 2024 and beyond.
More Posts
FDA Issues Final Rule and Guidance on Direct-To-Consumer Prescription Drug Advertisements
From Good Reprint Practices to SIUU Communications: What Firms Need to Know
OIG General Compliance Program Guidance November 2023
Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives
FDA’s Proposed Rule on LDT Regulation and the Debate over Agency Deference
FDA Clarifies Labeling Expectations for Prescription Drug Use-Related Software
Context is Key: FDA Sends a Strong Message About Efficacy Claims
FDA’s Office of Prescription Drug Promotion Issues Second Untitled Letter of the Year to Exeltis for Misleading Statements Relating to SLYND®
FDA Approves First Over-the-Counter Daily Oral Contraceptive
Subscribe: Subscribe via RSS